Retained Basal cells in Metastatic Prostate Cancer.

Absence of basal cells is well established as the sine qua non of prostatic adenocarcinoma.(1) However, basal cells may not identifiable on H&E sections while fibroblasts and compressed tumour cells can mimic basal cells.

Hence in morphologically equivocal cases immunohistochemistry using basal cell markers [high-molecular weight cytokeratin (HMWCK) and p63)] is used to establish a definitive diagnosis of invasive prostatic adenocarcinoma. This article is protected by copyright. All rights reserved.

Histopathology. 2016 Jan 08 [Epub ahead of print]

Murali Varma, Fouad S Alchami, David F R Griffiths

Department of Cellular Pathology, University Hospital of Wales, Cardiff, United Kingdom. , Department of Cellular Pathology, University Hospital of Wales, Cardiff, United Kingdom. , Department of Cellular Pathology, University Hospital of Wales, Cardiff, United Kingdom.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe